InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 188425

Tuesday, 12/23/2014 2:28:51 PM

Tuesday, December 23, 2014 2:28:51 PM

Post# of 345829

PRODUCT DESCRIPTION :
Product : Bavituximab
CAS# : 648904-28-3



Parchem Chemicals supply over 15,000 chemicals and many do not have to be FDA approved, depending on how they are specifically used. If used within medicine for medical treatment.. oncology, yes, of course it must be FDA approved.

Start tossing some connect the dots around, a short distance away from oncology and high unmet medical needs and hmmm, we just may be in for global Bavituximab demand in other areas that do not even need FDA approval.

Next, if one researches back on many of the FDA approved chemicals that appear under the Parchem site and analyze when it initially shows up at Parchem vs when they were FDA approved ( those chemicals used within oncology..etc that must be FDA approved ) and maybe some eyes will widen up a bit further

Astronomical I'd say

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News